NCT05030350Phase 3Terminated

Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)

Study sponsor: VistaGen Therapeutics, Inc. · VTGN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-09-23Actual
Enrollment · participants481Actual
Source updated2025-10-21Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview